Latest filing published 08 Jan 2024 for Core Laboratories Inc. /DE/, €45k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Kevin Daniels span 2 companies, the busiest being Core Laboratories N V and Core Laboratories Inc. /DE/. Between 1 July 2018 and 31 December 2023, the trades on record add up to 49 filings.
Every open-market trade on record is a sale: 2 sales worth €32k. Outside the open market, there are 24 share grants and 23 option exercises.
The record was last updated on 8 January 2024 with a share grant (€45k) in Core Laboratories Inc. /DE/. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations